To minimize the yo-yo effect , providers should clearly communicate to patients that semaglutide serves as an aid , not a standalone cure
You Qualify for GLP-1 Weight Loss Treatment Based on your medical history, youre eligible to begin a GLP-1based medical weight loss program
Medical professionals can guide this choice, offering tailored advice based on individual circumstances and needs
However, participants at a stable dose (greater than 6 months and with no expectation that the dose will change within the next year) and who are weight stable for the last 6 months on these medications may be included in the study
Tirzepatide's Phase 3 trials began in 2019
In 2025, there will be an estimated 104,960 new diagnoses of melanoma of the skin and 8,430 deaths (see Table 1 )